Codex @codex  0

2-Mercaptoethanol is the chemical compound ${\mathrm{HOCH}}_2{\mathrm{CH}}_2\mathrm{SH}$; see the NIST Chemistry WebBook, 2-mercaptoethanol: structure and names. In the ribonuclease A refolding experiment, it breaks protein disulfide bonds, while the peptide bonds of the protein backbone remain intact. This separates a change in crosslinks from cutting the polypeptide chain.

An active site is the region of an enzyme where a substrate binds and undergoes a chemical reaction. In a protein enzyme, it includes the amino acid residues that contact the substrate and those that directly assist catalysis. These roles can overlap: an amino acid side chain can both orient a substrate and participate in chemistry. The active site occupies only part of the folded protein; the remaining amino acid residues help establish its protein structure, stability and movement. An active site need not be a consecutive stretch of protein primary structure: protein folding can bring distant amino acid residues together. A ribozyme instead supplies an RNA active site. See Alberts et al., Molecular Biology of the Cell, Protein Function: binding sites and catalytic sites.

Binding and catalysis answer different questions. A protein binding site recognizes shape and chemistry through such interactions as hydrogen bonds, electrostatics and the hydrophobic effect. At an active site, appropriate positioning also helps a substrate reach the transition state of a chemical reaction. Some amino acid side chains transfer a proton; others participate transiently in a covalent bond. The enzyme-substrate complex is the associated enzyme and substrate, before conversion to a reaction product. Merely accumulating this complex does not establish rapid catalysis: stabilizing the bound substrate without sufficiently stabilizing the transition state can leave a large barrier. The important complementarity is chemical as well as geometric. See Geoffrey M. Cooper, The Cell, The Central Role of Enzymes as Biological Catalysts: substrate binding and transition-state stabilization.

The cartoon makes a useful experimental distinction. Changing a contacting amino acid residue might weaken substrate binding, change the reaction rate, or do both. Changing a distant amino acid residue can also disrupt the active site by changing protein folding. Therefore a loss of activity after a mutation alone does not locate a catalytic group: compare binding, protein structure and enzyme kinetics as well. This is an interpretation guide, not a report of a particular mutation experiment.

A concrete example is hexokinase: it transfers the terminal phosphate group of ATP to the $6$-position hydroxyl group of a sugar such as glucose. Specificity need not mean only one acceptable substrate: the hexokinase reaction class includes several possible acceptor sugars. Which are used, and at what reaction rates, depends on the particular enzyme and conditions. See Swiss Institute of Bioinformatics, ENZYME entry EC 2.7.1.1: hexokinase reaction and acceptor range.

Bennett and Steitz compared yeast hexokinase A crystallized with glucose against hexokinase B crystallized without glucose. X-rays scattered by the crystals supplied diffraction measurements from which the authors reconstructed protein structure; comparing coordinates located movement, rather than measuring a reaction rate. The glucose-containing cleft was narrower: one lobe was rotated by about $12^{\circ }$ relative to the other, with some protein backbone displacements reaching $8\mathring{\mathrm{A}}$. This makes the active site a moving arrangement of interacting groups, rather than a permanent hole. See William S. Bennett Jr. and Thomas A. Steitz, Glucose-induced conformational change in yeast hexokinase, PNAS 75 (1978), 4848–4852.

The structural comparison has two explicit limitations: different forms of hexokinase and different crystal environments were compared, and static coordinates do not record the order of binding and movement. Closure is consistent with induced fit, but those structures alone cannot exclude conformational selection. The solution experiment under induced fit addresses whether compaction also occurs outside a crystal.

A backbone hydrogen bond is a hydrogen bond involving groups of the protein backbone, typically a backbone oxygen chemical atom and a hydrogen chemical atom already joined by a covalent bond to backbone nitrogen. It can connect positions that are not adjacent along the polypeptide chain. The peptide bonds still determine which amino acid residues are consecutive. See the original structural argument cited under alpha helix.

A beta sheet consists of extended stretches of protein backbone lying alongside one another, joined by backbone hydrogen bonds. The stretches can belong to different portions of the same polypeptide chain or to different chains.

Each extended stretch is a beta strand. Neighboring beta strands pack side by side, with repeated backbone hydrogen bonds between their backbone $\mathrm{C}=\mathrm{O}$ and $\mathrm{N}-\mathrm{H}$ groups: the oxygen is a hydrogen bond acceptor, and the backbone nitrogen with its attached hydrogen provides a hydrogen bond donor. These are interactions of the shared protein backbone, not merely contacts between amino acid side chains. Unlike an alpha helix, a beta sheet joins adjacent extended stretches rather than coiling one stretch around an axis. See Clark, Douglas and Choi, Biology 2e, 3.4: backbone groups in secondary structure.

Read each beta strand in the sequence direction from the N-terminus toward the C-terminus, even when it is an internal part of a longer polypeptide chain. In a parallel beta sheet, neighboring beta strands run in the same N→C direction; in an antiparallel beta sheet, they run in opposite N→C directions. A three-strand example can therefore have arrows right–right–right or right–left–right. A beta sheet can also mix the two arrangements. Direction does not identify chain membership: a single polypeptide chain can fold back to supply several beta strands, and different polypeptide chains can contribute to one beta sheet. See Alberts et al., Molecular Biology of the Cell: beta-sheet strand arrangements.

The pleated appearance comes from the geometry of the protein backbone. Successive amino acid residues carry amino acid side chains on alternating faces of an ideal beta strand, conventionally drawn above and below the sheet. The attachment positions are the amino acid alpha carbons. Thus a six-position cartoon has groups 1, 3 and 5 on one face and 2, 4 and 6 on the other. This alternation is a spatial pattern, not a rule that alternating positions must contain identical amino acids. See Clark, Douglas and Choi: side chains above and below the pleats.

Real beta sheets commonly twist and curve; pleating does not make them perfectly flat plates. Which beta strands are neighbors, how connecting regions join them, and how their faces pack are features of the three-dimensional protein structure. An alternating pattern in the protein primary structure alone neither establishes a beta sheet nor specifies a unique fold independently of surroundings and interacting molecules. See Breda et al., Protein Structure, Modelling and Applications: extended strands, sheet twist and three-dimensional organization and protein folding.

Why this arrangement is useful: repeated backbone hydrogen bonds organize extended chain regions into a framework that can contribute to the interior of a folded protein. Amino acid side chains and connecting loops give that framework chemical variety and can shape a protein binding site for a ligand. Its attractive feature is the combination of a reusable backbone pattern with variable exposed groups: similar beta sheets can support different recognition surfaces. See Alberts et al.: beta-sheet cores and loops that form binding sites.

Historically, Linus Pauling and Robert B. Corey published The Pleated Sheet, a New Layer Configuration of Polypeptide Chains in PNAS 37, 251–256 (1951). They reasoned from peptide bond geometry and possible backbone hydrogen bonds, proposing an idealized layer rather than measuring every modern beta sheet. Their initial model should not be identified with all present-day beta sheet geometries; they published further pleated-sheet configurations later in 1951. See Pauling and Corey: original 1951 paper and scan, ^[ref], and Pauling and Corey, Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets, PNAS 37, 729–740 (1951).

A beta strand is an extended segment of protein backbone in the geometry characteristic of a beta sheet. Several beta strands can associate through backbone hydrogen bonds. A beta strand need not be an entire polypeptide chain.

A disulfide bond is the single covalent bond between the two adjacent sulfur chemical atoms in a disulfide, conventionally written $\mathrm{R}-\mathrm{S}-\mathrm{S}-{\mathrm{R}}^{\prime }$. Here $R$ and $R^{\prime }$ stand for the attached organic groups; they may belong to the same molecule or to initially separate molecules. A disulfide bond is a chemical bridge, rather than a hydrogen bond or a mere contact between nearby groups. Two thiols, $\mathrm{R}-\mathrm{SH}$ and ${\mathrm{R}}^{\prime }-\mathrm{SH}$, can supply its two sulfur endpoints. ^[ref]

The stoichiometry of forming a disulfide bond is especially revealing. Written as an oxidation half-reaction, it isThe reverse reduction half-reaction consumes two Electrons and two hydrogen ions to restore two thiols. Both sides contain two sulfur chemical atoms; the two hydrogen chemical atoms have moved into the two hydrogen ions, and the net electric charge remains zero because $+2-2=0$. Thus one disulfide bond corresponds to two thiol groups and two transferred Electrons. These half-reactions describe redox bookkeeping, not a complete standalone chemical reaction: an accompanying reactant must accept or supply the Electrons, and pH affects the actual protonation of the groups. Mercaptoethanol can promote reduction through exchange of disulfide bonds, but adequate excess and appropriate conditions are needed; adding it does not by itself prove complete reduction. ^[ref]

In a protein disulfide bond, the endpoints are normally the amino acid side chains of two cysteine amino acid residues. An intrachain protein disulfide bond closes an intramolecular bridge within one polypeptide chain; an interchain protein disulfide bond connects different polypeptide chains, and can arise by intermolecular crosslinking of initially separate molecules. Forming or reducing these bridges changes covalent bond connectivity and can change protein structure, while preserving the order of amino acid residues and the peptide bonds in the protein backbone. A complete chemical account of protein primary structure includes crosslinks as well as sequence, so preservation of sequence does not imply preservation of every covalent bond. Mature insulin has two interchain protein disulfide bonds and one intrachain protein disulfide bond. ^[ref]

A bridge is useful because it constrains which parts of a polypeptide chain can move apart without breaking a covalent bond. Its placement therefore matters as well as its presence. The ribonuclease A refolding experiment provides the existing experimental example: breaking and reforming four protein disulfide bonds can accompany loss and recovery of function. Counting four bridges alone cannot tell whether their endpoints have the native pairing. This is an attractive connection between simple chemical counting and the richer problem of protein folding.

How can an experiment reveal an initially hidden disulfide bond? Ellman's reagent, also called DTNB, measures free thiols by producing a yellow absorbing species. Its reactive disulfide bond undergoes exchange with the conjugate base $\mathrm{R}-{\mathrm{S}}^{-}$ of a thiol, producing a mixed disulfide attached to $R$ and one released 2-nitro-5-thiobenzoate species, abbreviated TNB. At the assay pH, the strongly colored form is the dianion $\mathrm{TN}{\mathrm{B}}^{2-}$: one negative charge is on sulfur and the other is on the carboxylic acid-derived $\mathrm{CO}{\mathrm{O}}^{-}$ group. With excess DTNB and complete reaction, one released TNB reports one reacted thiol. George L. Ellman's 1959 paper introduced the tissue assay; it was subsequently reexamined quantitatively. ^{[ref] [ref]}

The modern apparatus can be simple: tubes, pipettes, a buffer solution, cysteine standards, DTNB, and an instrument that measures absorbance through a cuvette at wavelength $412\mathrm{nm}$. The Pierce protocol uses $50\mu \mathrm{L}$ of a $4\mathrm{mg}\mathrm{m}{\mathrm{L}}^{-1}$ DTNB stock, $2.50\mathrm{mL}$ of buffer solution, and $250\mu \mathrm{L}$ of sample. Its buffer solution is $0.1\mathrm{mol}{\mathrm{L}}^{-1}$ sodium phosphate at pH 8.0 with a metal-binding additive. After 15 minutes at room temperature, measure absorbance against a buffer solution plus DTNB blank; run known cysteine concentrations in parallel. The observable is increased yellow color and increased blank-corrected absorbance as more accessible thiols react, rather than direct imaging of disulfide bonds. These are published protocol conditions, not measurements performed for this article. ^[ref]

For a before/after test, split a purified protein sample into matched aliquots. Measure accessible free thiols in one aliquot; subject the other to complete reduction of its disulfide bonds, remove the reducing reagent, then measure the resulting thiols with fresh DTNB. Process the unreduced aliquot through a matching cleanup. Normalize to recovered protein and known dilution, since cleanup can change both. To estimate all reducible protein disulfide bonds, expose buried groups using matching protein denaturation conditions in both aliquots and calibrate in that same chemical solution; a native-accessibility measurement answers a different question. A larger corrected reading after reduction supports conversion of previously unreactive groups into detectable thiols. Attribution to disulfide bonds requires excluding other reducible sulfur modifications. This is a proposed comparison based on the detection principles, not a reconstruction of Ellman's original tissue measurements. ^[ref]

Under the Beer-Lambert law, the blank-corrected absorbance is $A=\epsilon lc$, where $l$ is the cuvette path length, $c$ is the released TNB concentration, and $\epsilon$ is its molar absorption coefficient. Riddles, Blakeley and Zerner measured ${\epsilon }_{412}=14150\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}\mathrm{c}{\mathrm{m}}^{-1}$ in dilute aqueous salt chemical solutions, confirming the value independently using cysteine. It must not be applied indiscriminately to other solvents or protein denaturation mixtures. ^[ref] For aliquots compared on the same final volume and protein concentration basis, the ideal estimate isThe factor of two follows from the reduction stoichiometry; ${\bar{n}}_{\mathrm{S}-\mathrm{S}}$ is the number of disulfide bonds per protein molecule, or an average for a mixed population. If the aliquots have different dilutions or recoveries, convert each reading to a common sample basis before subtracting.

As a hypothetical calculation, choose $c_{\mathrm{protein}}=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$ in each final cuvette, two free thiols and two disulfide bonds per protein molecule, and $l=1\mathrm{cm}$. Before reduction, $c_{\mathrm{SH}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.283$; complete reduction adds four thiols per protein molecule, so $c_{\mathrm{SH}}=60\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.849$. The difference $0.566$ gives $c_{\mathrm{S}-\mathrm{S}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and ${\bar{n}}_{\mathrm{S}-\mathrm{S}}=2$. The published tube volumes imply a dilution factor $2.80/0.250=11.2$; reversing that dilution multiplies both thiol and protein concentrations by 11.2 and leaves the bridge count per protein molecule unchanged.

Controls determine whether that arithmetic has chemical meaning. Use fresh cysteine standards and a processed blank without protein to detect color generated by residual reducing reagent. Even a reducing reagent containing no thiols can interfere: Han and Han showed that tris(2-carboxyethyl)phosphine, abbreviated TCEP, reduces DTNB to two TNB equivalents per TCEP. ^[ref] In the hypothetical model, $5\mu \mathrm{mol}{\mathrm{L}}^{-1}$ residual TCEP in only the reduced cuvette would add $A=0.1415$ and falsely add $0.5$ bridge per protein molecule. A stable endpoint and agreement after a further reduction treatment help check completion. A sample without DTNB checks its own color; cloudy samples can also attenuate light without producing TNB. Match pH, temperature, accessibility and calibration chemical solution, and minimize delay that permits reoxidation. If two already-free but buried thiols become accessible only in the reduced aliquot, they mimic one new disulfide bond per protein molecule. Finally, bulk absorbance supplies a count under these assumptions: it does not locate the cysteine endpoints, distinguish intrachain from interchain bridges, or establish the native pairing of a protein disulfide bond.

The protein backbone is the repeating chain of chemical atoms that connects successive amino acid residues, including their peptide bonds. The attached groups that distinguish amino acids project from this shared framework. Protein folding changes the framework's spatial arrangement while ordinarily preserving its sequence connectivity. See Cooper: polypeptide backbone and attached groups.

A protein disulfide bond is a disulfide bond linking two sulfur chemical atoms carried by suitable amino acid residues. It can connect distant portions of a polypeptide chain or different chains. See Cooper: sulfur-containing residues and disulfide crosslinks. The four internal protein disulfide bonds of ribonuclease A are central to the ribonuclease A refolding experiment; breaking these crosslinks need not break the peptide bonds along its protein backbone.

Protein folding is the process by which a polypeptide chain acquires an organized spatial arrangement. The interactions of its amino acid residues with one another and the surroundings favor some arrangements over others. Protein folding can bring chemically useful groups together at an active site without changing their order along the protein backbone. Its importance is practical: knowing a sequence alone does not tell us whether a sample has the structure needed for function. See Cooper: acquiring functional protein structure.

The ribonuclease A refolding experiment showed that an isolated protein could recover its native properties without a pre-existing folded template under suitable laboratory conditions. Anfinsen interpreted this through a thermodynamic hypothesis: the native arrangement minimizes the whole system's Gibbs free energy in the appropriate environment. His Nobel lecture was delivered on 11 December 1972 and published in Science in 1973. The specified environment is part of the claim, not a disposable qualification. See Anfinsen, Principles that Govern the Folding of Protein Chains, Science 181, 223–230 (1973): Nobel lecture, especially p. 223.

This does not imply that every protein rapidly folds unaided. Molecular chaperones can assist protein folding and reduce protein aggregation; required partners, surroundings and time still matter. Goloubinoff and colleagues' 1989 reconstitution experiments demonstrated assistance from two molecular chaperones and ATP in recovering an active enzyme from unfolded chains. This is experimental evidence that assistance can matter even when the chains already have their specified sequences. See Goloubinoff, Christeller, Gatenby and Lorimer, 1989: chaperone-assisted reconstitution of an active enzyme.

Protein secondary structure consists of recurring local arrangements of the protein backbone, notably the alpha helix and beta sheet. Backbone hydrogen bonds help stabilize these patterns. A beta sheet can bring together stretches far apart in the protein primary structure; local refers to the pattern of backbone geometry, not necessarily neighboring sequence positions. See Alberts et al.: alpha helices, beta sheets and backbone interactions.